Trial Profile
BREATHER (PENTA 16) Short-Cycle Therapy (SCT) (5 Days on/2 Days Off) in Young People With Chronic HIV-infection
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Efavirenz (Primary) ; Abacavir; Didanosine; Emtricitabine; Lamivudine; Lamivudine/zidovudine; Nucleoside reverse transcriptase inhibitors; Stavudine; Tenofovir; Zidovudine
- Indications HIV-1 infections
- Focus Therapeutic Use
- Acronyms BREATHER; PENTA-16
- 16 Feb 2017 Results presented at the 24th Conference on Retroviruses and Opportunistic Infections
- 16 Jul 2013 Planned End Date changed from 30 Sep 2014 to 1 Jun 2014 as reported by ClinicalTrials.gov.
- 16 Jul 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.